… Receiving orphan drug designation highlights the significant unmet medical need that … cancer whose disease had progressed on gemcitabine plus cisplatin … drug designation for the treatment of biliary tract cancer. News release. FUJIFILM Pharmaceuticals …

Sound Pharmaceuticals is pleased to … insults such as noise, ototoxic drugs, or aging. Consequently, … chemotherapy (such as cisplatin or carboplatin). To date, no significant drug-drug … year. About Sound Pharmaceuticals Sound Pharma is a private biotechnology …

… enhances the chemosensitivity of esophageal cancer cells to cisplatin, with glutaminase … Hebei University of Chinese Medicine. Consent to participate … in its management. Biomed Pharmacothe. 2023;165:115183. doi … 47;HOXA1 axis. Anti-Cancer Drugs. 2023;34(4):495– …

… cancer undergoing interval cytoreductive surgery who received paclitaxel-based hyperthermic intraperitoneal chemotherapy … ] for advanced ovarian cancer. As cisplatin is the preferred drug according to strong …

… of Gastrointestinal Medical Oncology at Princess Margaret Cancer Centre in … -fluorouracil (5-FU) plus cisplatin (FP), or leucovorin plus 5 … ) plus combination chemotherapy in HER2-expressing gastrointestinal cancers, including gastroesophageal adenocarcinoma …

… invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as … -care neoadjuvant chemotherapy. Dr Michiel Van der Heijden, medical oncologist and … and gastroesophageal junction cancers. Imfinzi in combination with chemotherapy followed by …

… also HAIC regimens based on cisplatin or oxaliplatin, fluorouracil, and … Oncology School of Fujian Medical University at Fujian Cancer Hospital in Fuzhou … liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized …

… encouraging anti-tumor activity in cisplatin-ineligible patients with locally … eligible to receive platinum-based chemotherapy. Cohort 2 will enroll patients … untreated, cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer. J …

… therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer (RETAIN-2 … coverage. Ellimoottil is the medical director for telehealth and an … perioperative durvalumab with gemcitabine/cisplatin will impact the multidisciplinary care …

… 11 (SLC7A11). Cisplatin, a widely used chemotherapy drug, is effective against … negative breast cancer by inhibiting cancer-associated fibroblasts. Biochem Pharmacol. 2024; … mechanism and traditional Chinese medicine therapy. Front Pharmacol. 2022;13:969930 …